bearish
Quiddity Leaderboard STAR 50 Dec 23: One ADD and One DEL; Ninebot Could Underperform AIMA
886 Views17 Sep 2023 06:14
The Ninebot/AIMA share price ratio has failed to track the trend in the forward EPS ratios since mid-March 2023. The upcoming index outflow event could act as a catalyst for this ratio to dip.
Boomeranged on Wed, 25 Oct 2023 12:48
Final Expectations for the Dec 23 STAR 50 Rebalance: Sichuan Biokin Pharmaceutical (688506 CH) is an expected ADD and Ninebot (689009 CH) is an expected DEL. The SHORT Ninebot vs LONG AIMA Tech trade has started to move in the right direction and might be worth revisiting.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Quiddity Leaderboard T50/100 Dec 23: U-Ming Potential TDIV Deletion Is the Main Talking Point24 Oct 2023
- Quiddity Leaderboard SSE50/180 Dec 23: Triple Impact Possible for Hygon Info Tech (688041 CH)12 Oct 2023
- Quiddity Leaderboard CSI 300/500 Dec 23: Basket Trade Off to A Positive Start; US$2.8bn One-Way12 Oct 2023
- Quiddity Leaderboard STAR 50 Dec 23: One ADD and One DEL; Ninebot Could Underperform AIMA17 Sep 2023
- TOPIX Inclusions: Who Is Ready (Sep 2023)11 Sep 2023
- Quiddity ASX Sep 23 Rebal: 15 Inflow/Outflow Names; Beware of Short Buildup; US$450mn One-Way03 Sep 2023
- Quiddity Leaderboard CSI 300/500 Dec 23: US$2.5bn One-Way Turnover; Some Changes to Expectations17 Aug 2023
x